WHO ICTRP trial

Evaluation of the changes of hormone in polycystic ovarian syndrome, following…

IRCT20141230020486N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20141230020486N4
Public title Evaluation of the changes of hormone in polycystic ovarian syndrome, following ovarian drilling
Scientific title Evaluation of the changes of Anti-Mullerian hormone and antral follicle number in polycystic ovarian syndrome resistant to clomiphene citrate, following ovarian drilling
Primary sponsor Mashhad University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2
Countries Iran (Islamic Republic of);Iran (Islamic Republic of)
Conditions polycystic ovarian syndrome. Polycystic ovarian syndrome
Interventions Intervention group: Laparoscopic ovarian drilling is performed on patients with polycystic ovarian syndrome resistant to clomiphene. Then, 3 and 6 months after surgery (or until pregnancy), the levels of Anti-Mullerian hormone, androgens…
Registration date Aug 18, 2018
Target size 30
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations